Familial combined hyperlipidemia in children: Clinical expression, metabolic defects, and management

Familial combined hyperlipidemia (FCHL) is a dominantly inherited hyperlipidemia that occurs in at least 1% of the adult population and is responsible for 10% of premature coronary artery disease. In families referred for evaluation because of primary hyperlipidemia in a child, FCHL is expressed thr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of pediatrics 1993-08, Vol.123 (2), p.177-184
Hauptverfasser:	Cortner, Jean A., Coates, Paul M., Liacouras, Chris A., Jarvik, Gall P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Apolipoproteins B - blood Biological and medical sciences Child Child, Preschool children Cholesterol, HDL - blood Cholesterol, LDL - blood Cholestyramine Resin - therapeutic use Colestipol - therapeutic use Combined Modality Therapy Coronary Disease - etiology Disorders of blood lipids. Hyperlipoproteinemia Energy Intake familial incidence Female Genetic Linkage Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors hyperlipidemia Hyperlipidemia, Familial Combined - complications Hyperlipidemia, Familial Combined - genetics Hyperlipidemia, Familial Combined - metabolism Hyperlipidemia, Familial Combined - therapy Lipoproteins, VLDL - blood Liver - metabolism Male Medical sciences Metabolic diseases Multigene Family - genetics Niacin - therapeutic use Phenotype Polymorphism, Genetic Triglycerides - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!